Le Lézard
Classified in: Health
Subjects: EXE, POL, AVO

Trump Misses Target on Opioids: Down With Wall, Up With Port Security, Say Ex-WH Drug Spokesman Robert Weiner and Analyst Ben Lasky--Oped in Youngstown OH Vindicator


WASHINGTON, March 19, 2018 /PRNewswire-USNewswire/ -- Robert Weiner, the White House Drug Policy Spokesman under Presidents Bill Clinton and George Bush, said that President Trump's insistence on a wall again today, during his opioids announcement in New Hampshire, "misses the target on opioids and other drugs."  Weiner and policy analyst Ben Lasky wrote an oped just out in the Youngstown, OH Vindicator, "Down with the Wall, Up with Increased Port Security."  Weiner cited Cong Tim Ryan and other experts who found that 90% of the drugs coming into the country come through the port of entry. "The key is personnel to inspect container cargo," Weiner said today. 

Link to article:  http://www.vindy.com/news/2018/mar/18/down-with-wall-up-with-increased-port-se/

At today's announcement in New Hampshire, Trump insisted "Eventually the Democrats will agree with us to build the wall and to keep the damn drugs out." Weiner and Lasky pointed out that there has actually been a negative flow of immigration across the Southern Border?more people going back to Mexico than coming into the USA ? for the past decade. "Not only is the wall unnecessary because it misses where the drugs come from, it's unnecessary because the number of undocumented immigrants has been consistently decreasing, a fact little known," Weiner and Lasky wrote.  They cite a Pew 2017 study that found the number of undocumented immigrants in the U.S. is the lowest since 2005.

Weiner did commend parts of Trump's plan. In a statement today, Weiner said,

"The President is right to institute a massive advertising campaign.  Four-Star General/Drug Czar Barry McCaffrey, under President Clinton, instituted and carried out a five-year anti-drug TV advertising campaign that reduced youth drug use by 30% during McCaffrey and Clinton's last three years. Advertising works," Weiner said. "It was counterproductive later to zero out the advertising campaign, but drug legalizers and allies were successfully lobbying against it. I'm very glad the cycle is turning around to what works."

"Also, prevention, treatment as a whole, treatment for prisoners to avoid recidivism, and Narcan in emergencies to save lives from overdose, are excellent steps, as are prescription takebacks, reducing over-prescriptions for pain (but assuring still available when needed), messaging to stop parents from leaving drugs unattended in medicine cabinets, and reducing the prices of prescription drugs compared to other countries." 

Weiner took issue with promoting expanded death penalties. "In extreme cases it is necessary, but you can't kill your way out of the drug problem," Weiner asserted.

Weiner and Lasky concluded in their article, "Only a small percentage of containers are inspected. It is time for the U.S. to get serious about protecting ports of entry if it wants to seriously attack the country's opioid epidemic."

Weiner added today, "Moreover, if the White House is serious about opioids, they could start with maintaining the budget and staff of the White House Drug Policy Office instead of again, as they tried to do last year, wanting to nearly zero it out."

Contact: Robert Weiner/Ben Lasky 301-283-0821, cell 202-306-1200 [email protected]

SOURCE Robert Weiner Associates and Solutions for Change


These press releases may also interest you

at 06:05
AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March 25-31 as National Physicians Week. This week and throughout the year, we celebrate the dedication of physicians who selflessly...

at 06:00
The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027" report has been added to  ResearchAndMarkets.com's...

at 05:45
The "Global Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product, and Place, with Executive & Consultant Guides; Including Customized Forecasting and Analysis" report has been added to  ResearchAndMarkets.com's offering....

at 05:45
The Gross Law Firm issues the following notice to shareholders of InMode Ltd. . Shareholders who purchased shares of INMD during the...

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...

at 05:20
IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, today announced that China National Medical Products Administration (NMPA) has approved the...



News published on and distributed by: